Announcing Winners of the 2024 Marble Center Poster Symposium
On May 21, 2024, the MIT community as well as members the Industry Affiliate program at the Marble Center in Nanomedicine (IAMNano) participated in a poster symposium organized by the Marble Center for Cancer Nanomedicine to discuss nano- and precision-based approaches for the early detection and treatment of a variety of diseases, including cancer.
From Left-Right: Prof. Bob Langer, Dr. Tamara Dacoba (Hammond Lab), Dr. Alice Stanton (Langer and Tsai Labs), Jason Zhang (Irvine and Love labs), Dr. Qian Zhong (Bhatia Lab), and Prof. Sangeeta Bhatia.
Fifteen research posters were selected for this event, representing 20 research investigators from various institutes and departments at MIT, the Koch Institute, the Broad Institute, Beth Israel Deaconess Medical Center, Scripps Research Institute, Dana–Farber/Harvard Cancer Center, the Ragon Institute, and Brigham and Women’s Hospital, among many others.
We are grateful for our wonderful panel of judges who helped us select this year’s winners: Drs. Alessandro Amici (FUJIFILM Life Sciences), Rosalind Firenze (MIT), Jay Godfrey (MIT), Melissa Lokugamage (Alloy Therapeutics Venture Studio), Jessica Miles (Holtzbrinck Publishing Group), and Miao-Chih Tsai (Stanford).
The winners of this year’s poster symposium are:
Tamara Dacoba, PhD from the Hammond Lab for her poster on “Protein Corona Impacts Association and Trafficking of Layer-by-Layer Nanoparticles.”
Alice Stanton, PhD from the Langer and Tsai Labs for her poster on “Advanced Brain Mimicry In Vitro: 3D Immuno-Glial-Neurovascular miBrainPlatform.”
Y. Jason Zhang from the Love and Irvine Labs for his poster on “Vaccines Combining Sustained Antigen Delivery and Follicle-Targeting Improve Humoral and Germinal Center Responses.”
Qian Zhong, PhD from the Bhatia Lab for his poster on “Targeted granzyme B Delivery with Conditional Nanocarriers Induces Pyroptosisand Synergizes with Checkpoint Inhibitors in Immunological Cold Tumors.”
